The effect of tafamidis treatment on cardiovascular aging in patients with Transthyretin cardiomyopathy. An observational study.

Back

ESC Professional Premium Access

The effect of tafamidis treatment on cardiovascular aging in patients with Transthyretin cardiomyopathy. An observational study.

Session: Heart disease in the elderly: treatment and outcomes

Topic: Cardiovascular Disease in the Elderly

Speaker: Doctor D. Delialis (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Dimitrios Delialis

Alexandra University Hospital, Athens (Greece)

0 follower

6 more presentations in this session

Potential cardioprotective effects of acetylcholinesterase inhibitors in patients with Alzheimer's disease

Speaker: Doctor L. Rampa (Milan, IT)

Age disparity among severe aortic stenosis patients: AVR treatment rates and clinical outcomes among octogenarians

Speaker: Mr O. Shimoni (IL)

Outcomes of catheter ablation for ventricular tachycardia in the geriatric population

Speaker: Doctor G. Kowlgi (Rochester, US)

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Speaker: Doctor G. Armentaro (Catanzaro, IT)

Adverse cardiovascular outcomes and sex-specific differences among older adults with cardiac ageing

Speaker: Associate Professor R. Tan (Singapore, SG)

Access the full session

Heart disease in the elderly: treatment and outcomes

Speakers: Doctor D. Delialis, Doctor L. Rampa, Mr O. Shimoni, Doctor G. Kowlgi, Doctor G. Armentaro...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources